Quality & Safety
概述
Clinical outcomes are generally defined as the result of health care services or interventions on the health status of a patient. In value-based care, the significant measures of quality are the outcomes that matter.
When outcomes are measured and reported, it fosters further improvement and adaption of the best latest practices towards the ultimate goal of advancing patient outcomes and improved patient care at Cardiac Vascular Sentral Kuala Lumpur (CVSKL).
冠脉血管成形及支架植入术
A total of 3642 PCI procedures were performed at CVSKL between year 2020 to 2023
The median length of stay (LOS) were 2 days respectively for all PCI procedures performed between year 2020 to 2022 and 1 day for procedures performed in year 2023.
The rate of in-hospital mortality for patients undergoing PCI procedures at CVSKL is lower compared to the rate of in-hospital mortality reported by the National Cardiovascular Disease Database (NCVD) for PCI.
消融术
A total of 911 ablation procedures were performed at CVSKL between year 2020 to 2023.
The median length of stay (LOS) were 2 days respectively for all ablation procedures performed between year 2020 to 2023.
There were no mortality cases reported for ablation procedures performed between years 2020 to 2023
Device Implant
A total of 251 device implant procedures were performed at CVSKL between year 2020 to 2023.
The median length of stay (LOS) were 2 days respectively for all device implant procedures performed between year 2020 – 2023.
There was no mortality reported for device implant procedures performed in year 2020, 2022 and 2023. However, 1 (1.7%) death was reported in year 2021.
Isolated Elective Low Risk (EURO Score <2) Coronary Artery Bypass Grafting (CABG)
A total of 445 Isolated Elective Low Risk (EURO Score<2) CABG procedures were performed at CVSKL between year 2020 to 2023.
The median post-surgery length of stay (LOS) were 6 days in year 2020 and 2022 and 8 days in year 2021 and 2023
The mortality rate reported was 0% for years 2020,2021 and 2023. There was 1 death (1.5%) reported in year 2022. The overall survival rate for 2020-2023 was 99.78% (mortality rate 0.22%).
Endovascular Aneurysm Repair (EVAR), Thoracic Endovascular Aneurysm Repair (TEVAR) & Customized Medical Devices (CMD)
A total of 131 EVAR, TEVAR & CMD procedures were performed at CVSKL between year 2020 to 2023
The median length of stay (LOS) were 4 days respectively for all EVAR, TEVAR & CMD procedures performed between year 2020 to 2023.
There mortality rate for EVAR, TEVAR & CMD procedures were 4.3% in year 2020, 2.9% in year 2021, 3.1% in year 2022 and 4.8% in year 2023.
Peripheral Arterial Disease – Angioplasty
A total of 255 Angioplasty procedures for Peripheral Arterial Disease (PAD) were performed at CVSKL between year 2020 to 2023.
The median length of stay (LOS) were 3 days respectively for all PAD-Angioplasty procedures performed between year 2020 to 2023.
There were 2 (4.2%) and 3 (4.0%) deaths reported in year 2020 and 2023 respectively. No mortality was reported in year 2021 and 2022.
Peripheral Arterial Disease (PAD) – Bypass
A total of 51 Bypass procedures for Peripheral Arterial Disease (PAD) were performed at CVSKL between year 2020 to 2023. 
The median length of stay (LOS) was 8 days in year 2020 and 6 days in year 2021 and 2022 and 7 days in year 2023.
There was 1 (9.1%) death reported in year 2020 and no mortality cases reported between year 2021 and 2023.
Infection Control Outcome
At Cardiac Vascular Sentral Kuala Lumpur (CVSKL), our ultimate focus is not limited to infection control as we strongly emphasize on infection prevention. The paramount role of infection prevention reduces the risk of hospital-acquired infections, thus protecting and providing a safe environment for our patients, employees, visitors, and everyone walking through our doorstep.
Patient Satisfaction Survey Outcome
Patient satisfaction evaluation is a key step in moving toward patient-centred care. At Cardiac Vascular Sentral Kuala Lumpur (CVSKL), every patient feedback is seen as an opportunity for us to improve to progress towards excellent patient experience at all times. The hospital-wide patient satisfaction survey results are a reflection of both outpatient and inpatients, rating our services as “Excellent” and “Good”.
曾获得国际奖项与认证，是马来西亚最好的心脏医院之一。
亚太地区最佳新医院奖
全球健康与旅游奖
亚太区2018年
年度心胸外科最佳人物奖
全球健康与旅游奖
亚太区2020年
年度心脏病服务提供商奖
全球健康与旅游奖
亚太区2021年
马来西亚健康质量协会(MSQH)
认证 （2019 ∼ 2023）
年度最佳心脏血管护理医院
BrandLaureate 国际企菁年度品牌奖2023
Data validated by Quality Assurance, CVSKL